Which patents cover Nortrel 1/35-21, and what substitute generic drugs are available?Nortrel 1/35-21 is a drug marketed by Barr and is included in one NDA.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
ethinyl estradiol; norethindrone
|TABLET;ORAL-21||072693-001||Feb 28, 1992||RX||No||No||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.